CULTURALLY ADAPTED DIALECTICAL BEHAVIOR THERAPY FOR LOW-MIDDLE-INCOME COUNTRIES
Culturally Adapted Dialectical Behavior Therapy (DBT) for Mental Health in LMICs: A Randomized Controlled Trial (RCT)
1 other identifier
interventional
220
1 country
1
Brief Summary
The study aims to assess the efficacy of culturally adapted dialectical behaviour therapy (DBT) for addressing emotional dysregulation in a low- and middle-income country, as well as to evaluate the impact of DBT on secondary outcomes such as borderline personality traits, self-harm or suicide, depression, anxiety, and individuals' functioning and disability. Through a rigorous Randomised Controlled Trial (RCT), the research seeks to assess how cultural adaptations of dialectical behaviour therapy improve its applicability, engagement, and outcomes in diverse socio-cultural settings, contributing to more accessible and effective mental health interventions in resource-limited regions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
November 20, 2025
CompletedStudy Start
First participant enrolled
November 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
November 28, 2025
November 1, 2025
6 months
November 15, 2025
November 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Emotional dysregulation
As measured through participants' scores on the Difficulties in Emotion Regulation Scale-16 item version (DERS-16)
18 Months
Self-harm or suicide
As measured through the participants' scores on the Self-Harm Inventory, as well as the presence of any suicide attempt in participants' history
18 months
Secondary Outcomes (3)
Borderline traits
18 months
Depression and anxiety
18 months
Functioning and disability
18 months
Study Arms (2)
Culturally adapted DBT+Treatment as usual
EXPERIMENTALIn addition to the usual treatment (TAU), which typically involves pharmacotherapy or supportive counselling from a general physician, participants will receive culturally translated and adapted dialectical behaviour therapy (DBT) materials that fit local cultural and linguistic contexts. Such material will include culturally relevant metaphors, examples, and mindfulness practices. Sessions will be conducted in the form of weekly group skills training (emotion regulation, distress tolerance, interpersonal effectiveness, mindfulness), individual therapy sessions (1 hour/week), and telephone coaching as needed.
Treatment as usual (TAU) only
NO INTERVENTIONParticipants will only receive standard mental health care available in the region (e.g., medication, supportive counselling), usually from a general physician. TAU in Pakistan largely consists of pharmacological treatment with medication and follow-up in an outpatient basis.
Interventions
Participants will receive culturally translated and adapted dialectical behaviour therapy (DBT) materials that fit local cultural and linguistic contexts. Such material will include culturally relevant metaphors, examples, and mindfulness practices. Sessions will be conducted in the form of weekly group skills training (emotion regulation, distress tolerance, interpersonal effectiveness, mindfulness), individual therapy sessions (1 hour/week), and telephone coaching as needed.
Eligibility Criteria
You may qualify if:
- Adults aged 18-45 years
- Adults who are diagnosed with or have significant traits of borderline personality disorder (BPD)
- Adults who are willing to provide written informed consent
You may not qualify if:
- Severe psychiatric comorbidity (e.g., active psychosis, substance use, etc.)
- Acute medical conditions interfering with participation
- Lack of basic reading and writing, or any learning disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pakistan Association of Cognitive Therapists
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mirrat G. Butt, PhD
PACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2025
First Posted
November 20, 2025
Study Start
November 20, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share